Future-Ready India: The Trends Reshaping Leadership and Growth
India on the verge of becoming clinical trials hub, Parexel executive saysIndia is poised to become a prominent site for early-stage clinical trials, particularly amid the disruptions caused by the Russia-Ukraine ...
India’s Growing Prowess as a Global Leader in Healthcare Innovation
India emerging as a hub for clinical trials, says Parexel"In the past, if they wanted to do clinical trials in 28 countries, India used to be 20th on the list. But, now, India started popping up a...
Diversity, Flexibility, Empowerment top HR priorities for firms: ETILCOwing to the change in operations, corporates have recalibrated their HR strategies. Many have shifted their focus to agility, flexibility,...
CCI clears Phoenix Parentco's acquisition of Parexel International CorporationThe proposed transaction pertains to acquisition of 100 per cent of the equity shareholding of Parexel International, according to a notice...
Technology is going to play a key role in India's roadmap for health infrastructure: ETILC membersThe use of technology to gather and make data more accessible and usable is one of the biggest changes in the Indian healthcare system. We’...
UK begins major trial for new inhaler-based COVID-19 treatmentSynairgen's SG018 trial is a randomised placebo-controlled study being conducted in approximately 20 countries enrolling a total of 610 COV...
Job of the Week: BiostatisticianBiostatistics is the science of obtaining, analysing and interpreting data using statistical theory and methods to address problems in biol...
Drug companies hire consultants like Lachman Consultants, Parexel to offset USFDA heatInterestingly, a few top Indian drug firms such as Lupin and Glenmark have shifted to a model of engaging these consultants on a continuous...
- Biotech cos eye global JVs for R&D push
These initiatives are happening at a time when pharmaceutical companies, too, seem unable to find takers for their molecules in a challengi...
- Ranbaxy upbeat as US Dept of Justice withdraws motion
Pharmaceutical major Ranbaxy Labortaories today said it remained confident that its products were safe and effective as the US Department o...
- US likely to withdraw motion against Ranbaxy
US Dept of Justice has said legal consultancy firm hired by Ranbaxy has produced nearly five lakh documents so far and intends to share rem...
- US Department of Justice to withdraw motion against Ranbaxy
Department Of Justice to withdraw motion to subpoena if company submits all audit documents in frauds case.
- Ranbaxy denies charges, points finger at rivals
Four days after the news of US government’s legal action against India’s largest drugmaker became public, Ranbaxy CEO and MD Malvinder Sing...
- Ranbaxy refutes DoJ's adulteration charges
Ranbaxy has refuted the charges levelled against it by US Department of Justice of not sharing audit information sought by US authorities. ...
- Ranbaxy faces adulteration charges in US
US department of justice has said there was evidence to suggest that Ranbaxy used active pharmaceutical ingredients from unapproved sources...